Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma 53Lymphoma, Non-Hodgkin 36Lymphoma, Large B-Cell, Diffuse 34Lymphoma, Follicular 28Lymphoma, Mantle-Cell 26Glioblastoma 25Central Nervous System Neoplasms 25Hodgkin Disease 22Gliosarcoma 21Astrocytoma 21Lymphoma, Large-Cell, Immunoblastic 20Brain Neoplasms 20Burkitt Lymphoma 18Leukemia, Lymphocytic, Chronic, B-Cell 17Multiple Myeloma 15Glioma 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Oligodendroglioma 12Lymphoma, B-Cell, Marginal Zone 11Leukemia 10Neoplasms, Plasma Cell 9Recurrence 7Lymphoma, B-Cell 5Waldenstrom Macroglobulinemia 4Medulloblastoma 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, T-Cell 4Leukemia, Myeloid, Acute 4Ependymoma 4Lymphoma, Large-Cell, Anaplastic 3

Interventions

Carboplatin 10Temozolomide 9Filgrastim 7Vincristine 4Irinotecan 4Etoposide 4Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3O(6)-benzylguanine 3Granulocyte Colony-Stimulating Factor 3Vorinostat 2Psychiatric Rehabilitation 2Oxaliplatin 2Lenalidomide 2Cilengitide 2Busulfan 2veliparib 1trioctyl phosphine oxide 1tipifarnib 1romidepsin 1pomalidomide 1pazopanib 1lonafarnib 1laromustine 1ixabepilone 1ispinesib 1imetelstat 1exatecan 1emvododstat 1cediranib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Optic Nerve Glioma × Carmustine × Clear all
NCT00003765 2013-02-05

O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors

National Cancer Institute (NCI)

Phase 1 Completed
36 enrolled
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡